Antiplatelet therapy as a modulator of stroke aetiology: a meta‐analysis
ConclusionsAntiplatelet therapy preferentially reduces the incidence of LAA stroke compared to CE and SVO subtypes.
Source: British Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Authors: Christopher A. Rajkumar, Christopher N. Floyd, Albert Ferro Tags: Meta‐analysis Source Type: research
More News: Aspirin | Atrial Fibrillation | Cardiology | Databases & Libraries | Drugs & Pharmacology | Heart | Ischemic Stroke | Stroke | Study | Thrombosis